국가: 아일랜드
언어: 영어
출처: HPRA (Health Products Regulatory Authority)
CYPERMETHRIN
Novartis Animal Vaccines Ltd
QP53AC
10 Mg/l
Concentrate for solution
Ectoparasiticide
Fish - (Atlantic) Salmon
1999-08-23
IRISH MEDICINES BOARD ACT 1995 EUROPEAN COMMUNITIES (ANIMAL REMEDIES) (NO. 2) REGULATIONS 2007 (S.I. NO. 786 OF 2007) VPA: 10974/022/001 Case No: 7004014 The Irish Medicines Board in exercise of the powers conferred on it by Animal Remedies (No. 2) Regulations (S.I. No. 786 of 2007) hereby grants to: NOVARTIS ANIMAL VACCINES LTD 4 WARNER DRIVE, SPRINGWOOD INDUSTRIAL ESTATE, RAYNE ROAD, ESSEX CM7 2YW, UNITED KINGDOM an authorisation, subject to the provisions of the said Regulations and the general conditions of the attached authorisation, in respect of the Veterinary Medicinal Product: EXCIS The particulars of which are set out in Part 1 and Part 2 of the said Schedule. The authorisation is also subject to any special conditions as may be specified in the said Schedule. The authorisation,unless revoked, shall continue in force from 11/04/2008 until 21/07/2009. Signed on behalf of the Irish Medicines Board ________________ A person authorised in that behalf by the said Board. (NOTE: This authorisation replaces any previous authorisation in respect of this product which is now null and void.) IRISH MEDICINES BOARD ________________________________________________________________________________________________________________________ _Date Printed 15/04/2008_ _CRN 7004014_ _page number: 1_ PART II SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Excis. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION 1% w/v cypermethrin (cis 40 : trans 60) in an ethanolic base. For a full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM A clear, yellow tinted, non-aqueous, cutaneous solution for water-borne use. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Farmed Atlantic salmon (Salmo salar). 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES The product is indicated for the treatme 전체 문서 읽기